Literature DB >> 17992120

Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level.

Amalia A Vartanian1, Olga S Burova, Eugeniya V Stepanova, Anatoly Yu Baryshnikov, Mikhail R Lichinitser.   

Abstract

The concept of 'vasculogenic mimicry' (VM) was introduced to describe the unique ability of highly invasive tumor cells to form capillary-like structures (CLS) and matrix-rich patterned network in three-dimensional culture that mimic embryonic vasculogenic network. Recently, we have shown that CLS formation requires apoptotic cell death through activation of caspase-3-dependent mechanism. In this study, to identify some molecular determinants driving aggressive melanoma cells to express a latent 'angiogenic program' that recapitulates the early events of CLS formation, we focused on the involvement of antioxidants (AOs) in the process of melanoma VM. We have studied the effects of resveratrol, (-)-epigallocathechin gallate, N-acetyl-cysteine (NAC) and Trolox on the ability of melanoma cells to form/destroy CLS. We observed that the formation of CLS was strongly related to reactive oxygen species level. In vivo animal experiments confirmed the involvement of reactive oxygen species level in melanoma VM. To understand the molecular mechanisms of this phenomenon, we specifically looked for induction of apoptosis and vascular endothelial growth factor (VEGF) release. Western blot analysis revealed that the level of VEGF, VEGF receptors (VEGF-Rs) and active caspase-3 dramatically decreased in cells treated with AOs. Here, we also report further experiments designed to determine whether the crosstalk between AOs and apoptosis exists in melanoma VM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992120     DOI: 10.1097/CMR.0b013e3282f1d2ec

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  12 in total

1.  Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.

Authors:  Hai-Bo Wu; Shuai Yang; Hai-Yan Weng; Qian Chen; Xi-Long Zhao; Wen-Juan Fu; Qin Niu; Yi-Fang Ping; Ji Ming Wang; Xia Zhang; Xiao-Hong Yao; Xiu-Wu Bian
Journal:  Autophagy       Date:  2017-08-16       Impact factor: 16.016

2.  Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

Authors:  Yue-Zu Fan; Wei Sun
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 3.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

Review 4.  Hypoxia-independent drivers of melanoma angiogenesis.

Authors:  Svenja Meierjohann
Journal:  Front Oncol       Date:  2015-05-05       Impact factor: 6.244

Review 5.  Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.

Authors:  Daniel Delgado-Bellido; Santiago Serrano-Saenz; Mónica Fernández-Cortés; F Javier Oliver
Journal:  Mol Cancer       Date:  2017-03-21       Impact factor: 27.401

Review 6.  Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.

Authors:  Hong Ge; Hui Luo
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

7.  Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.

Authors:  Changhwan Yeo; Deok-Soo Han; Hyo-Jeong Lee; Eun-Ok Lee
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

8.  BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.

Authors:  H Maes; S Van Eygen; D V Krysko; P Vandenabeele; K Nys; K Rillaerts; A D Garg; T Verfaillie; P Agostinis
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

9.  Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation in vivo.

Authors:  Sainan Gao; Chao Fan; Hua Huang; Changlai Zhu; Min Su; Yuquan Zhang
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

Review 10.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.